• Since inception, Foundation has supported 1,094 patients from 54 nationalities, including 602 children
  • Foundation has invested AED74 million to provide relief to patients suffering from chronic illnesses and life-threatening conditions 

Government of Dubai Media Office:Al Jalila Foundation, a global philanthropic organisation dedicated to transforming lives through medical education and research, announced that it has received a donation of AED1 million from Dubai Islamic Bank (DIB) to support its A’awen programme which helps patients in need.

Al Jalila Foundation through its A’awen programme provides financial aid for medical care to patients in the UAE who are unable to afford quality treatment. Since its inception in 2013, Al Jalila Foundation has supported 1,094 patients from 54 nationalities, including 602 children, and has provided assistance worth AED74 million to provide relief to patients suffering from a number of chronic illnesses and life-threatening conditions. The treatment costs for patients, newborn to 90 years of age, have ranged from to AED 20,000 to AED 250,000 per individual.

Dr Abdulkareem Sultan Al Olama, the Chief Executive Officer of Al Jalila Foundation, welcomed the Dubai Islamic Bank team, to the Foundation to engrave the name of DIB on Bassmat Rashid Bin Saeed, the first robotic donor recognition wall of its kind, marking the bank’s generosity and support. Dr Abdulkareem said: "We are extremely grateful to Dubai Islamic Bank for its longstanding support to our A’awen programme and delighted to see their name on Bassmat Rashid Bin Saeed alongside fellow Champions of Hope. It is a privilege to work with distinguished banking and financial institutions like DIB to make a difference to patients’ lives."

Dedicated to the late Sheikh Rashid bin Saeed Al Maktoum, renowned for his humanitarian achievements, Bassmat Rashid Bin Saeed is a unique humanitarian campaign that uses cutting-edge technology to recognise the donor community’s contributions to advancing local medical research to save patients’ lives.  For more information on how to be a part of Bassmat Rashid Bin Saeed please visit www.aljalilafoundation.ae/bassmat.


Al Jalila Foundation

Al Jalila Foundation, a global healthcare philanthropic organisation dedicated to transforming lives, was founded by His Highness Sheikh Mohammed Bin Rashid Al Maktoum, Vice-President and Prime Minister of the United Arab Emirates (UAE) and Ruler of Dubai in April 2013, to position Dubai and the UAE at the forefront of medical innovation.

Al Jalila Foundation supports medical treatment for individuals unable to afford quality healthcare; provides scholarships to nurture a home-grown generation of medical professionals and supports ground-breaking research that addresses health challenges prevalent in the region: cancer, cardiovascular diseases, diabetes, obesity and mental health. In response to the COVID-19 global pandemic, Al Jalila Foundation expanded its research portfolio to address the coronavirus and other emerging diseases effecting mankind.

In August 2020, His Highness Sheikh Mohammed inaugurated the Mohammed Bin Rashid Medical Research Institute, a AED 300 million multi-disciplinary research centre established by Al Jalila Foundation to be a beacon of hope for the UAE and the Arab region.

Al Jalila Foundation is named after Her Highness Sheikha Al Jalila Bint Mohammed Bin Rashid Al Maktoum, the daughter of His Highness Sheikh Mohammed Bin Rashid Al Maktoum.

Al Jalila Foundation is one of 33 member organisations under the Mohammed Bin Rashid Al Maktoum Global Initiatives which embodies the vision of His Highness Sheikh Mohammed Bin Rashid Al Maktoum to improve the Arab world through humanitarian, developmental and community work.

For more information please visit: www.aljalilafoundation.ae 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.